Dynamically growing company engaged in development and production of high-quality Russian innovate medicines.

RDIF has invested in Geropharm, a Russian pharmaceutical company, specializing in restoring brain function and the treatment of diabetes.

This investment utilized the mechanism designed to promote the development of companies with significant export potential.

Key facts

  • The construction of a high-tech full-cycle production complex in St. Petersburg
  • The development of new drugs and exports
  • Year of investment: 2016.

Investment strategy

Import substitution and development of export potential
Improvement in industrial efficiency